The past two years have seen exciting advances in the world of genomics, as several companies threaten to disrupt the next-gen sequencing (NGS) establishment. Meanwhile, advances in spatial omics, single-cell biology, proteomics and multiomics are revealing new insights into complex biology in health and disease.

In this 4-hour event–The State of Omics—leaders from the world of genome technology, analysis, NGS and multiomics offer a pulsating view of the rapid progress in this field. They will present on and discuss the arrival and application of groundbreaking new technologies that place the human genome into a richer biological context than ever before and offer a pulsating view of the rapid progress in this field.